In addition, in secondary phagocytic syndromes caused by (non-viral) infections, adjuvant corticosteroids or anti-cytokine therapy targeting IL-1 or IL-6 may be used to accelerate recovery and/or improve survival (20–23). Here, IL6 is linked to infection.